Spots Global Cancer Trial Database for metastatic sarcoma
Every month we try and update this database with for metastatic sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Feasibility of Intraoperative Visualization With Cytalux in Children | NCT06235125 | Osteosarcoma Pulmonary Metas... Fluorescence Metastatic Sarc... Pediatrics | Cytalux | 6 Years - 17 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma | NCT05711615 | Metastatic Leio... Metastatic Sarc... Metastatic Soft... Unresectable Le... Unresectable Sa... Unresectable So... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Pegylated Lipos... Peposertib | 18 Years - | National Cancer Institute (NCI) | |
| A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs | NCT06228326 | Lung Cancer, No... Lung Cancer Met... Solid Tumor, Ad... Advanced Cancer Lung Cancer, Sm... Metastatic Colo... Metastatic Rena... Metastatic Hepa... Metastatic Sarc... Metastatic Oste... | KB707 | 18 Years - | Krystal Biotech, Inc. | |
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma | NCT03168061 | Solid Tumor Soft Tissue Sar... Metastatic Sarc... Sarcoma | NC 6300 | 18 Years - 80 Years | NanoCarrier Co., Ltd. | |
| A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma | NCT05835154 | Metastatic Sarc... Sarcoma | Assessment Questionnaire A... Interview Electronic Heal... | 18 Years - | Fred Hutchinson Cancer Center | |
| Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma | NCT00902044 | Sarcoma | Autologous HER2... Fludarabine Cyclophosphamid... Autologous CAR ... | - | Baylor College of Medicine | |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | NCT05488366 | Sarcoma, Soft T... | Pembrolizumab Radiation thera... | 18 Years - | University of California, Irvine | |
| Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors | NCT04771520 | Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Mela... Metastatic Prim... Metastatic Sarc... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Prognostic Stag... Prognostic Stag... Stage IIIC Colo... Stage IIIC Lung... Stage IV Colore... Stage IV Lung C... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color... | Avapritinib | 18 Years - | M.D. Anderson Cancer Center | |
| Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study | NCT04430725 | Lung Non-Small ... Metastatic Colo... Metastatic Sarc... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Colore... Stage IV Lung C... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color... | Computed Tomogr... Microwave Ablat... Questionnaire A... Wedge Excision | 18 Years - | M.D. Anderson Cancer Center | |
| 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma | NCT04457258 | Metastatic Sarc... Recurrent Sarco... Sarcoma | Computed Tomogr... Gallium Ga 68 F... Positron Emissi... 18F-FDG | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas | NCT01106872 | Sarcoma Soft Tissue Sar... Locally Advance... Unresectable Sa... Metastatic Sarc... | Bevacizumab, Ge... | 18 Years - 99 Years | University of Iowa | |
| Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) | NCT04595747 | Locally Advance... Locally Advance... Metastatic Gast... Metastatic Sarc... Stage III Gastr... Stage III Small... Stage IV Gastri... Stage IV Small ... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Positron Emissi... Rogaratinib | 18 Years - | National Cancer Institute (NCI) | |
| A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma | NCT05835154 | Metastatic Sarc... Sarcoma | Assessment Questionnaire A... Interview Electronic Heal... | 18 Years - | Fred Hutchinson Cancer Center | |
| Intravital Microscopy in Human Solid Tumors | NCT03823144 | Solid Tumor, Ad... Clinical Stage ... Gastric Carcino... Malignant Solid... Metastatic Colo... Metastatic Gast... Metastatic Prim... Metastatic Sarc... Postneoadjuvant... Resectable Colo... Resectable Live... Resectable Panc... Resectable Sarc... Stage IV Colore... | Diagnostic Micr... Fluorescein Sod... | 18 Years - | Mayo Clinic | |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas | NCT04906876 | Sarcoma Soft Tissue Sar... Metastatic Sarc... Undifferentiate... Myxofibrosarcom... Leiomyosarcoma Liposarcoma Angiosarcoma Synovial Sarcom... Rhabdomyosarcom... Spindle Cell Sa... High Grade Sarc... Bone Sarcoma | Gemcitabine Docetaxel 9-ING-41 | 10 Years - | Brown University | |
| Dendritic Cell Vaccine for Children and Adults With Sarcoma | NCT01803152 | Sarcoma Soft Tissue Sar... Bone Sarcoma | Dendritic Cells... Lysate of Tumor Gemcitabine Imiquimod Leukapheresis | 1 Year - 100 Years | University of Miami | |
| YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma | NCT05448820 | Advanced Sarcom... Metastatic Sarc... Soft Tissue Sar... | YH001 Envafolimab Doxorubicin | 18 Years - | Tracon Pharmaceuticals Inc. | |
| Intravital Microscopy in Human Solid Tumors | NCT03823144 | Solid Tumor, Ad... Clinical Stage ... Gastric Carcino... Malignant Solid... Metastatic Colo... Metastatic Gast... Metastatic Prim... Metastatic Sarc... Postneoadjuvant... Resectable Colo... Resectable Live... Resectable Panc... Resectable Sarc... Stage IV Colore... | Diagnostic Micr... Fluorescein Sod... | 18 Years - | Mayo Clinic | |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | NCT01491594 | Sarcoma, Soft T... Osteosarcoma Neoplasms, Conn... | Eltrombopag | 18 Years - 82 Years | Duke University | |
| A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas | NCT02448537 | Metastatic Sarc... | PM01183 Doxorubicin Gemcitabine | 18 Years - 75 Years | Massachusetts General Hospital | |
| Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma | NCT04199026 | Metastatic Sarc... Recurrent Sarco... Resectable Sarc... | Doxorubicin Doxorubicin Hyd... Drug Delivery M... Everolimus Ganitumab Ifosfamide Irinotecan Pazopanib Polyethylene Gl... Temozolomide Temsirolimus Therapeutic Con... Vincristine | 10 Years - | M.D. Anderson Cancer Center | |
| Mix Vaccine for Metastatic Sarcoma Patients | NCT03357315 | Metastatic Sarc... Reaction - Mixe... | Mix vaccine | 40 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas | NCT01106872 | Sarcoma Soft Tissue Sar... Locally Advance... Unresectable Sa... Metastatic Sarc... | Bevacizumab, Ge... | 18 Years - 99 Years | University of Iowa | |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype | NCT04741438 | Sarcoma | Nivolumab and I... Pazopanib Oral ... | 18 Years - | Centre Leon Berard | |
| Safety and Feasibility of Intraoperative Visualization With Cytalux in Children | NCT06235125 | Osteosarcoma Pulmonary Metas... Fluorescence Metastatic Sarc... Pediatrics | Cytalux | 6 Years - 17 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) | NCT03520959 | Synovial Sarcom... Cancer Soft Tissue Sar... Sarcoma Metastatic Sarc... | LV305 G305 LV305-matching ... G305-matching p... | 12 Years - | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia | NCT01491594 | Sarcoma, Soft T... Osteosarcoma Neoplasms, Conn... | Eltrombopag | 18 Years - 82 Years | Duke University | |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | NCT05488366 | Sarcoma, Soft T... | Pembrolizumab Radiation thera... | 18 Years - | University of California, Irvine | |
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma | NCT03168061 | Solid Tumor Soft Tissue Sar... Metastatic Sarc... Sarcoma | NC 6300 | 18 Years - 80 Years | NanoCarrier Co., Ltd. | |
| Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma | NCT00902044 | Sarcoma | Autologous HER2... Fludarabine Cyclophosphamid... Autologous CAR ... | - | Baylor College of Medicine | |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype | NCT04741438 | Sarcoma | Nivolumab and I... Pazopanib Oral ... | 18 Years - | Centre Leon Berard | |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype | NCT04741438 | Sarcoma | Nivolumab and I... Pazopanib Oral ... | 18 Years - | Centre Leon Berard | |
| A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas | NCT01112384 | Metastatic Sarc... | SB939 | 16 Years - | Canadian Cancer Trials Group | |
| Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial | NCT04693377 | Castration-Resi... Metastatic Colo... Metastatic Mali... Metastatic Mali... Metastatic Mela... Metastatic Pros... Metastatic Rena... Metastatic Sarc... Metastatic Thyr... Metastatic Urot... Stage IV Colore... Stage IV Prosta... Stage IV Renal ... Stage IVA Color... Stage IVA Prost... Stage IVB Color... Stage IVB Prost... Stage IVC Color... | Cryosurgery Quality-of-Life... Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma | NCT04457258 | Metastatic Sarc... Recurrent Sarco... Sarcoma | Computed Tomogr... Gallium Ga 68 F... Positron Emissi... 18F-FDG | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study | NCT04430725 | Lung Non-Small ... Metastatic Colo... Metastatic Sarc... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Colore... Stage IV Lung C... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color... | Computed Tomogr... Microwave Ablat... Questionnaire A... Wedge Excision | 18 Years - | M.D. Anderson Cancer Center | |
| Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma | NCT00902044 | Sarcoma | Autologous HER2... Fludarabine Cyclophosphamid... Autologous CAR ... | - | Baylor College of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
